You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
药明生物(02269.HK)十个交易日来首升近4% 曾触及20天线
阿思达克 09-11 14:11
本周一起正式「染蓝」药明生物(02269.HK)终止由纪录高位九连吐,午後曾重越上月初遭股东减持价185元及触及20天线(185.4元),最高见185.4元,现造184.9元,回升3.9%,成交259万股,涉资4.74亿元。

药明生物上月初再次遭大股东WuXi Biologics Holdings(由公司董事长兼非执董李革控制)较市价折让6.7%每股185元配售近3,300万股,套现逾61亿元。配售完成後,其持股将由25.77%降至约23.35%,仍为公司单一大股东。WuXi Biologics今年来已多次减持,曾分别於1月、4月及5月三度配股,年内总共减持约2亿股,套现逾240亿元。另外,药明生物亦曾於6月底以每股137元,配售4,500万股,集资筹净额61.22亿元。

恒指接近2时曾高见24,519,现造24,470,反覆回升157点或0.6%,但成交额仅630亿元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account